Barbera L, et al. - Using linked provincial administrative data, researchers performed this retrospective cohort study consisting of 7,431 individuals to determine the factors associated with opioid use in patients with cancer surviving > 5 years without recurrence. They assessed exposures of opioid use before cancer diagnosis, opioid use between cancer diagnosis, and 5-year anniversary, surgeries, and chemotherapy. A higher rate of opioid use after the index was noted to be most strongly associated with a continuous opioid use between diagnosis and index. Higher risk of post-index date opioid use was also observed in correlation with opioid use prior to diagnosis, a history of depression, comorbidity and > 2 years of diabetes. They identified safe and appropriate pain management as a significant survivorship issue.